Definitive Contract HHSN268201600028C
- Not listed
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
- This is a $1,725,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The contract is for the development of targeted molecular imaging agents to detect high-risk atherosclerotic plaque, in combination with existing imaging modalities. Ocean Nano TECH LLC is a nanotechnology...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $1,292,182, is for the development of a haptoglobin treatment to reduce complications of sickle cell disease. The contract is a definitive, firm-fixed-price contract with a period of performance ending on June...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Molecular Targeting Technologies, Inc. (MTTI), a small disadvantaged business. The $222,581 firm fixed-price contract supports the development of target-specific molecular imaging agents to be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This SBIR contract falls under Topic 85 and is set...
- This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
- <p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Aphios Corp, a minority-owned for-profit small business. The contract has a ceiling value of $149,440 and a completion date of December 14, 2011. It was awarded on June 15, 2011 under the SBIR program to support research related to Topic 43. SBIR contracts provide early-stage funding to small businesses for the development of innovative...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $148,235.00, is for research into using haptoglobin as a treatment to reduce complications of sickle cell disease. The contract has a firm-fixed price and was awarded on August 1, 2012, with a target completion date of March 15, 2013.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a "Multiplex Label-Free Nanowell Technology for Early Cardiotoxicity Biomarkers" under SBIR Topic #97. This Phase I effort aims to develop a novel diagnostic platform to detect early indicators of cardiotoxicity, which is an important capability for advancing drug development and patient care. As an SBIR Phase I contract, this award supports the initial feasibility and proof-of-concept stage of the technology.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE | PHS-2016-1 | Department of Health and Human Services National Institutes of Health | Award Notice 2/3 | 9/19/16, 11:34 AM | |
A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS - PHS-2016-1 | PHS-2016-1 | Department of Health and Human Services National Institutes of Health | Award Notice 3/3 | 9/19/16, 11:42 AM | |
A Low Cost Integrated Method for Isolation of M. Tuberculosis DNA from Raw Sputum | PHS-2016-1 | Department of Health and Human Services National Institutes of Health | Award Notice 1/3 | 7/2/15, 3:21 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | $0 | 7/24/17 | |
| Not listed | Not listed | $249.7k | 8/4/16 |